Viral and protozoal vaccines. THERAPEUTIC ENZYMES. Monoclonal antibodies
At the centre of the CIBEX platform is the unicellular ciliate microorganism tetrahymena thermophila. Due to its outstanding properties, it is considered a "workhorse" in the life sciences.
In addition to the endeavour to optimise the CIBEX platform for the general production of therapeutic enzymes, Cilian is also developing therapeutic proteins in three different sectors.
CIFLU
Tetravalent protein sub-unit vaccine for the treatment of seasonal and pandemic flu
Ciliate Lipase
Recombinant lipase enzyme - e.g. for the treatment of exocrine pancreatic insufficiency (EPI)
CIMAB
Production of monoclonal antibodies based on the CIBEX expression system.
